BEAM - Beam Therapeutics Inc
IEX Last Trade
26.72
-0.120 -0.449%
Share volume: 389,929
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$26.84
-0.12
-0.45%
Summary score
12%
Profitability
0%
Dept financing
10%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.31%
Return on assets
-7.83%
Return on sales
-379819.48%
Return on invested capital
-278.48%
Total debt ratio
38.23%
Debt ratio change over timeo
-1.23%
Current Ratio
5.41%
Quick Ratio
5.41%
Cash Position Ratio
5.2%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.7%
Return on assets
-3.62%
Return on sales
-625.2%
Return on invested capital
-85.88%
Total debt ratio
36.32%
Debt ratio change over timeo
-1.11%
Current Ratio
5.46%
Quick Ratio
5.46%
Cash Position Ratio
5.34%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-10.8%
Return on assets
-7.66%
Return on sales
-1405.29%
Return on invested capital
-193.97%
Total debt ratio
32.82%
Debt ratio change over time
-0.9%
Current Ratio
5.99%
Quick Ratio
5.99%
Cash Position Ratio
5.85%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-90.41%
Return on assets
-94.49%
Return on sales
535839.02%
Return on invested capital
-6.89%
Total debt ratio
-122.67%
Debt ratio change over time
-1.23%
Current Ratio
-4.4%
Quick Ratio
-4.4%
Cash Position Ratio
-4.25%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | BEAM | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -13.31% | 13.79% | 34.47% | 7.43% |
Return on assets | -7.83% | 2.76% | 3.15% | 5.62% |
Return on sales | -379819.48% | 28.74% | 32.53% | 40.48% |
Return on invested capital | -278.48% | 2.36% | 5.39% | 19.77% |
Profitability | 0% | 43% | 66% | 80% |
Total debt ratio | 38.23% | 90.46% | 90.54% | 26.74% |
Debt ratio change over time | -1.23% | 308.97% | -6.99% | 1.18% |
Dept financing | 11% | 50% | 25% | 7% |
Current Ratio | 5.46% | 0.91% | 2.18% | 5.4% |
Quick Ratio | 5.46% | 0.8% | 1.79% | 4.64% |
Cash Position Ratio | 5.34% | 0.36% | 1.28% | 2.93% |
Liquididy | 75% | 9% | 21% | 48% |
Short-term ratios | BEAM | ABBV | AMGN | REGN |
---|---|---|---|---|
Return on equity | -4.7% | 13.77% | 13.25% | 3.8% |
Return on assets | -3.62% | 2.43% | 1.89% | 3.09% |
Return on sales | -625.2% | 24.64% | 23.72% | 30.49% |
Return on invested capital | -85.88% | 2.14% | 3.39% | 9.18% |
Profitability | 0% | 71% | 68% | 82% |
Total debt ratio | 36.32% | 92.14% | 93.05% | 21.79% |
Debt ratio change over time | -1.11% | 46.38% | -72.08% | 1.51% |
Dept financing | 10% | 50% | 25% | 7% |
Current Ratio | 5.46% | 0.91% | 2.18% | 5.4% |
Quick Ratio | 5.46% | 0.8% | 1.79% | 4.64% |
Cash Position Ratio | 5.34% | 0.36% | 1.28% | 2.93% |
Liquididy | 75% | 10% | 24% | 60% |